首先,使用 RosetteSep™ 人脐带血 CD34 预富集混合物 (15896C) 预富集造血祖细胞,并识别 T 细胞、B 细胞、髓样细胞和血小板表面标志物的抗体进行预富集。然后使用含有识别 CD34 的抗体的 EasySep™ 人 CD34 阳性选择混合物 (18096C) 选择 CD34+ 细胞。
产品名称:CB-CD34-Hematopoietic Stem Cells 产品型号: 产品展商:ABM 产品文档:无相关文档 简单介绍 CB-CD34-Hematopoietic Stem Cells CB-CD34-Hematopoietic Stem Cells的详细介绍 Print Version SafetyBioSafety Level II OrganismHuman Source OrganCord Blood ...
从CB-MNCs中分离CD34+细胞 从CB-MNCs中分离CD34+细胞 试剂和材料: 1. 培养基; 2. 过柱缓冲液:pH7.2的PBSA,添加0.5%牛血清白蛋白和2mmol/L EDTA或0.6%枸橼酸葡萄糖A方(ACD-A)。用真空装置除去缓冲液中的气体; 3. FcR阻断剂; 4. CD34微 从CB-MNCs中分离CD34+细胞 试剂和材料: 1. 培养基; 2. 过柱...
BCR-ABL-transformed human CB CD34+ show proliferative disadvantage and markedly reduced replating capacity upon ELMO1 depletion.Marta E. CapalaEdo VellengaJan Jacob Schuringa
1 vial amount:-+ Add cart description literature download Related products Products Description CD34 is a glycosylated transmembrane protein and represents a well-known marker for primitive blood- and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial stem cells. Although th...
A human bone marrow-derived mesenchymal stromal cell (MSCs) and cord blood-derived CD34+ stem cell co-culture system was set up in order to evaluate the proliferative and differentiative effects induced by MSCs on CD34+ stem cells, and the reciprocal influences on gene expression profiles. After...
In vivo injection into NSG mice further indicated that the CB CD34+CD38−CD110+ population is highly enriched in HSCs compared with both CD34+CD38−CD110− and CD34+CD38− populations. Together our results validate MAb1.6.1 as an important tool, which has so far been lacking, in the...
单次采集获得CD34+细胞产量过高是否预示淋巴瘤患者自体干细胞移植预后不良? 背景 多因素可影响复发淋巴瘤患者自体造血干细胞移植(HSCT)后的估计生存率,包括年龄、合并症、肿瘤类型、突变和肿瘤微环境。虽然对淋巴瘤的动员数据进行了大量研究,...
所以造血干细胞移植中自体干细胞移植的肿瘤细胞清除和异基因干细胞移植中急慢性移植物抗宿主病(GVHD)的发生一直是倍受关注的问题,CD34+细胞绝对计数检测技术的发展使这一问题的解决成为可能,并推动了干细胞移植在临床上的应用。 什么是CD34+细胞? CD34是一种表达在...
Sequential high-dose chemotherapy may increase the threshold dose of CD34+ cells necessary for rapid and successful hematologic recovery. There are limited data regarding the pharmacodynamics and threshold CD34+ cell dose required for engraftment following high-dose paclitaxel. To determine the dose of ...